409 related articles for article (PubMed ID: 16146549)
1. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?
Duclos-Vallée JC; Yilmaz F; Johanet C; Roque-Afonso AM; Gigou M; Trichet C; Féray C; Ballot E; Dussaix E; Castaing D; Bismuth H; Samuel D; Guettier C
Clin Transplant; 2005 Oct; 19(5):591-9. PubMed ID: 16146549
[TBL] [Abstract][Full Text] [Related]
2. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
Hum Pathol; 2002 Nov; 33(11):1098-104. PubMed ID: 12454814
[TBL] [Abstract][Full Text] [Related]
3. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
[TBL] [Abstract][Full Text] [Related]
4. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program.
Nayak NC; Vasdev N; Saigal S; Soin AS
Hum Pathol; 2010 Mar; 41(3):425-30. PubMed ID: 19954815
[TBL] [Abstract][Full Text] [Related]
5. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
Ong J; Younossi ZM; Reddy V; Price LL; Gramlich T; Mayes J; Boparai N
Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
[TBL] [Abstract][Full Text] [Related]
6. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
[TBL] [Abstract][Full Text] [Related]
7. Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy.
Sutedja DS; Gow PJ; Hubscher SG; Elias E
Transplant Proc; 2004 Oct; 36(8):2334-7. PubMed ID: 15561241
[TBL] [Abstract][Full Text] [Related]
8. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
Caldwell SH; Oelsner DH; Iezzoni JC; Hespenheide EE; Battle EH; Driscoll CJ
Hepatology; 1999 Mar; 29(3):664-9. PubMed ID: 10051466
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis.
Heneghan MA; Zolfino T; Muiesan P; Portmann BC; Rela M; Heaton ND; O'grady JG
Liver Transpl; 2003 Sep; 9(9):921-8. PubMed ID: 12942453
[TBL] [Abstract][Full Text] [Related]
10. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
Seyam M; Neuberger JM; Gunson BK; Hübscher SG
Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation.
Gibelli NE; Tannuri U; Mello ES; Cançado ER; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Pinho-Apezzato ML; Maksoud JG
Pediatr Transplant; 2006 May; 10(3):371-6. PubMed ID: 16677364
[TBL] [Abstract][Full Text] [Related]
13. [The role of liver biopsy in the diagnosis of autoimmune hepatitis].
Szabó Z
Orv Hetil; 2006 Sep; 147(35):1697-702. PubMed ID: 17051746
[TBL] [Abstract][Full Text] [Related]
14. Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence.
Nakhleh RE; Krishna M; Keaveny AP; Dickson RC; Rosser B; Nguyen JH; Steers JL
Transplant Proc; 2005 Mar; 37(2):1240-2. PubMed ID: 15848682
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for autoimmune hepatitis: a long-term pathologic study.
Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
Hepatology; 2000 Aug; 32(2):185-92. PubMed ID: 10915722
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
[TBL] [Abstract][Full Text] [Related]
18. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.
Ward SC; Chang CY; Peng L; Liu LU
Semin Liver Dis; 2009 May; 29(2):233-7. PubMed ID: 19387922
[TBL] [Abstract][Full Text] [Related]
19. Cryptogenic cirrhosis and NAFLD: are they related?
Maheshwari A; Thuluvath PJ
Am J Gastroenterol; 2006 Mar; 101(3):664-8. PubMed ID: 16464222
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
